The proangiogenic and drug-resistant biomarkers, HIF-1α and -2α, miRs-210/-155, Nrf2, and TGF-β, are overexpressed in the majority of primary and metastatic ccRCC tumors. This evidence concerns the gene NFE2L2 and nonpapillary renal cell carcinoma.